Several UBQLN2 gene mutations have been linked to ALS and FTD as reviewed by Renaud and collaborators in 2019 [162], and many transgenic UBQLN2 rodent models have been developed. This evidence concerns the gene UBQLN2 and amyotrophic lateral sclerosis.